Challenging chemoresistant metastatic colorectal cancer: therapeutic strategies from the clinic and from the laboratory.

Challenging chemoresistant metastatic colorectal cancer: therapeutic strategies from the clinic and from the laboratory.

Item
http://www.wikidata.org/entity/Q38827897
miR-4775 promotes colorectal cancer invasion and metastasis via the Smad7/TGFβ-mediated epithelial to mesenchymal transition.Pooled Analysis of Clinical Outcome of Patients with Chemorefractory Metastatic Colorectal Cancer Treated within Phase I/II Clinical Studies Based on Individual Biomarkers of Susceptibility: A Single-Institution Experience.Current and future biomarkers in the treatment of colorectal cancer.Plasticity of Resistance and Sensitivity to Anti-Epidermal Growth Factor Receptor Inhibitors in Metastatic Colorectal Cancer.Specific inhibition of p110α subunit of PI3K: putative therapeutic strategy for KRAS mutant colorectal cancersDishevelled1-3 contribute to multidrug resistance in colorectal cancer via activating Wnt/β-catenin signaling.Targeting the human epidermal growth factor receptor 2 (HER2) oncogene in colorectal cancer.
P2860

Challenging chemoresistant metastatic colorectal cancer: therapeutic strategies from the clinic and from the laboratory.

Item
http://www.wikidata.org/entity/Q38827897
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Challenging chemoresistant met ...... linic and from the laboratory.
@en
type
label
Challenging chemoresistant met ...... linic and from the laboratory.
@en
prefLabel
Challenging chemoresistant met ...... linic and from the laboratory.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
Challenging chemoresistant met ...... linic and from the laboratory.
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P921